Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
5-13 |
VAR |
denotes |
variants |
T1 |
17-22 |
GENE |
denotes |
PPARG |
T2 |
28-37 |
NEGREG |
denotes |
decreased |
T3 |
38-46 |
MPA |
denotes |
activity |
T4 |
80-90 |
REG |
denotes |
associated |
T5 |
96-105 |
POSREG |
denotes |
increased |
T6 |
121-129 |
DISEASE |
denotes |
diabetes |
T7 |
131-179 |
GENE |
denotes |
Peroxisome proliferator-activated receptor gamma |
T8 |
181-186 |
GENE |
denotes |
PPARG |
T9 |
343-359 |
NEGREG |
denotes |
loss-of-function |
T10 |
361-364 |
NEGREG |
denotes |
LOF |
T11 |
366-375 |
VAR |
denotes |
mutations |
T12 |
379-384 |
GENE |
denotes |
PPARG |
T13 |
398-409 |
REG |
denotes |
cosegregate |
T14 |
415-428 |
DISEASE |
denotes |
lipodystrophy |
T16 |
433-440 |
GENE |
denotes |
insulin |
T15 |
433-451 |
DISEASE |
denotes |
insulin resistance |
T17 |
491-495 |
NEGREG |
denotes |
P12A |
T18 |
496-503 |
VAR |
denotes |
variant |
T19 |
525-534 |
NEGREG |
denotes |
decreased |
T20 |
543-558 |
DISEASE |
denotes |
type 2 diabetes |
T21 |
560-563 |
DISEASE |
denotes |
T2D |
T22 |
587-595 |
VAR |
denotes |
variants |
T23 |
599-604 |
GENE |
denotes |
PPARG |
T24 |
609-616 |
NEGREG |
denotes |
defects |
T25 |
730-735 |
GENE |
denotes |
PPARG |
T26 |
872-877 |
GENE |
denotes |
PPARG |
T27 |
888-891 |
GENE |
denotes |
MAF |
T28 |
1042-1045 |
DISEASE |
denotes |
T2D |
T29 |
1073-1081 |
MPA |
denotes |
function |
T30 |
1092-1100 |
VAR |
denotes |
variants |
T31 |
1221-1228 |
NEGREG |
denotes |
reduced |
T32 |
1229-1237 |
MPA |
denotes |
activity |
T33 |
1279-1282 |
NEGREG |
denotes |
LOF |
T34 |
1283-1291 |
VAR |
denotes |
variants |
T35 |
1296-1306 |
REG |
denotes |
associated |
T36 |
1326-1334 |
POSREG |
denotes |
increase |
T37 |
1346-1349 |
DISEASE |
denotes |
T2D |
T38 |
1521-1528 |
VAR |
denotes |
variant |
T39 |
1532-1537 |
GENE |
denotes |
PPARG |
T40 |
1535-1540 |
GENE |
denotes |
RG th |
T41 |
1543-1550 |
NEGREG |
denotes |
reduces |
T42 |
1551-1559 |
MPA |
denotes |
function |
T43 |
1610-1620 |
REG |
denotes |
associated |
T44 |
1628-1639 |
POSREG |
denotes |
substantial |
T45 |
1648-1651 |
DISEASE |
denotes |
T2D |
R0 |
T0 |
T2 |
CauseOf |
variants,decreased |
R1 |
T0 |
T5 |
CauseOf |
variants,increased |
R10 |
T14 |
T13 |
ThemeOf |
lipodystrophy,cosegregate |
R11 |
T14 |
T19 |
ThemeOf |
lipodystrophy,decreased |
R12 |
T15 |
T9 |
ThemeOf |
insulin resistance,loss-of-function |
R13 |
T15 |
T10 |
ThemeOf |
insulin resistance,LOF |
R14 |
T15 |
T13 |
ThemeOf |
insulin resistance,cosegregate |
R15 |
T15 |
T19 |
ThemeOf |
insulin resistance,decreased |
R16 |
T17 |
T19 |
CauseOf |
P12A,decreased |
R17 |
T21 |
T9 |
ThemeOf |
T2D,loss-of-function |
R18 |
T21 |
T10 |
ThemeOf |
T2D,LOF |
R19 |
T21 |
T13 |
ThemeOf |
T2D,cosegregate |
R2 |
T1 |
T0 |
ThemeOf |
PPARG,variants |
R20 |
T21 |
T19 |
ThemeOf |
T2D,decreased |
R21 |
T22 |
T24 |
CauseOf |
variants,defects |
R22 |
T23 |
T22 |
ThemeOf |
PPARG,variants |
R23 |
T30 |
T31 |
CauseOf |
variants,reduced |
R24 |
T32 |
T31 |
ThemeOf |
activity,reduced |
R25 |
T33 |
T35 |
CauseOf |
LOF,associated |
R26 |
T33 |
T36 |
CauseOf |
LOF,increase |
R27 |
T34 |
T33 |
CauseOf |
variants,LOF |
R28 |
T34 |
T35 |
CauseOf |
variants,associated |
R29 |
T34 |
T36 |
CauseOf |
variants,increase |
R3 |
T3 |
T2 |
ThemeOf |
activity,decreased |
R30 |
T37 |
T33 |
ThemeOf |
T2D,LOF |
R31 |
T37 |
T35 |
ThemeOf |
T2D,associated |
R32 |
T37 |
T36 |
ThemeOf |
T2D,increase |
R33 |
T38 |
T41 |
CauseOf |
variant,reduces |
R34 |
T39 |
T38 |
ThemeOf |
PPARG,variant |
R35 |
T42 |
T41 |
ThemeOf |
function,reduces |
R36 |
T45 |
T41 |
ThemeOf |
T2D,reduces |
R37 |
T45 |
T43 |
ThemeOf |
T2D,associated |
R38 |
T45 |
T44 |
ThemeOf |
T2D,substantial |
R4 |
T10 |
T9 |
CauseOf |
LOF,loss-of-function |
R5 |
T11 |
T9 |
CauseOf |
mutations,loss-of-function |
R6 |
T11 |
T10 |
CauseOf |
mutations,LOF |
R7 |
T12 |
T11 |
ThemeOf |
PPARG,mutations |
R8 |
T14 |
T9 |
ThemeOf |
lipodystrophy,loss-of-function |
R9 |
T14 |
T10 |
ThemeOf |
lipodystrophy,LOF |